Published in Br J Clin Pharmacol on October 01, 1984
Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol (1986) 1.56
Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol (1991) 1.25
Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children. CPT Pharmacometrics Syst Pharmacol (2013) 1.01
Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers. Br J Clin Pharmacol (1987) 0.97
Impaired absorption of paracetamol in vegetarians. Br J Clin Pharmacol (1993) 0.87
Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. Br J Clin Pharmacol (1988) 0.86
Covariates of intravenous paracetamol pharmacokinetics in adults. BMC Anesthesiol (2014) 0.84
Time course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells. Xenobiotica (2015) 0.83
Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol. Br J Clin Pharmacol (1987) 0.81
Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen. Clin Pharmacokinet (2016) 0.78
Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen. Br J Clin Pharmacol (2015) 0.78
An open label pilot study to evaluate the efficacy of Spanish black radish on the induction of phase I and phase II enzymes in healthy male subjects. BMC Complement Altern Med (2014) 0.75
Exposure to acetaminophen and all its metabolites upon 10, 15 and 20 mg/kg intravenous acetaminophen in very preterm infants. Pediatr Res (2017) 0.75
Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol (1980) 1.87
High performance liquid chromatographic estimation of paracetamol metabolites in plasma. Br J Clin Pharmacol (1978) 1.78
Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol (1977) 1.76
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. J Pharm Sci (1971) 1.35
Drug metabolism by the gastrointestinal mucosa. Clin Pharmacokinet (1981) 1.33
Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol (1979) 1.30
Metabolism of isoprenaline in the intestine. J Pharm Pharmacol (1974) 1.12
The influence of the route of administration on urinary metabolites of isoetharine. Xenobiotica (1974) 0.92
Determination of paracetamol and its metabolites in urine by high-performance liquid chromatography using ion-pair systems. J Chromatogr (1978) 0.89
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J (1979) 6.45
A meta-analysis of studies using bias and precision statistics to compare cardiac output measurement techniques. J Clin Monit Comput (1999) 4.76
Hand washing for preventing diarrhoea. Cochrane Database Syst Rev (2008) 4.42
Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet (1971) 4.40
Successful treatment of severe paracetamol overdosage with cysteamine. Lancet (1974) 3.83
Mefenamic acid nephropathy. Lancet (1980) 3.80
Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption. Br Med J (1973) 3.77
Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics (1967) 3.60
Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet (1976) 3.41
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol (1973) 3.26
Treatment of drug overdosage with naloxone, a specific narcotic antagonist. Lancet (1973) 3.16
Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00
Treatment of salicylate poisoning with repeated oral charcoal. Br Med J (Clin Res Ed) (1985) 2.90
Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J (Clin Res Ed) (1982) 2.90
Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J (1966) 2.68
Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res (1976) 2.63
Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med (1972) 2.56
Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem (2001) 2.56
Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci U S A (1987) 2.43
Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther (1978) 2.41
Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol (1973) 2.31
Narcotic analgesics and delayed gastric emptying during labour. Lancet (1975) 2.24
Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol (1975) 2.18
Gas-liquid chromatographic estimation of paracetamol. J Pharm Pharmacol (1971) 2.16
Pharmacokinetic drug interactions. Lancet (1969) 2.07
Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet (1979) 2.06
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Henry Matthew: the father of modern clinical toxicology. J R Coll Physicians Edinb (2009) 2.04
The chief scientist reports ... prevention of hepatic necrosis following paracetamol overdosage. Health Bull (Edinb) (1978) 2.03
Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol (1972) 2.03
Factors determining the maintenance dose of warfarin in Chinese patients. QJM (1996) 2.03
Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol (1977) 2.01
Acute haemolysis and renal failure after nomifensine overdosage. Br Med J (1980) 2.00
Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. Health Technol Assess (2007) 1.98
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem (1987) 1.88
Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol (1980) 1.87
Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology (1997) 1.87
Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease. J Epidemiol Community Health (2003) 1.84
Direct determination of surface tension in the lung. Proc Natl Acad Sci U S A (1976) 1.83
Functions of the alveolar lining. Am Rev Respir Dis (1977) 1.81
High performance liquid chromatographic estimation of paracetamol metabolites in plasma. Br J Clin Pharmacol (1978) 1.78
Absorption, distribution and elimination of mexiletine. Postgrad Med J (1977) 1.74
Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth (1981) 1.71
Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs (1983) 1.70
Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Q J Med (1985) 1.65
Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol (1985) (1995) 1.61
Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments. BMJ (1998) 1.57
Metabolism and turnover of lung surfactant. Am Rev Respir Dis (1987) 1.56
Herb-induced aconitine poisoning. Lancet (1993) 1.56
Generic inequivalence--clinical observations. Acta Pharmacol Toxicol (Copenh) (1971) 1.55
Pulmonary surfactant and its apoproteins. J Clin Invest (1990) 1.55
Smoking and diabetes in Chinese men. Postgrad Med J (2001) 1.55
Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet (1982) 1.54
Effects of non-narcotic analgesics on the liver. Drugs (1986) 1.50
Isolation of apoproteins from canine surface active material. Am J Physiol (1973) 1.49
Gastrointestinal absorption of drugs. Med Clin North Am (1974) 1.49
Pulmonary surface film stability and composition. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.48
Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol (1986) 1.48
Evaluation of pressure-driven captive bubble surfactometer. J Appl Physiol (1985) (1994) 1.48
Drugs prescribed for self poisoners. Br Med J (Clin Res Ed) (1985) 1.44
Paracetamol poisoning and hepatotoxicity in Chinese--the Prince of Wales Hospital (Hong Kong) experience. Singapore Med J (1993) 1.42
Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb. J Appl Physiol (1975) 1.41
Subfractionation of lung surfactant. Implications for metabolism and surface activity. Biochim Biophys Acta (1983) 1.40
Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab (1974) 1.40
Analgesic abuse and renal disease in North-East Scotland. Lancet (1966) 1.40
Paracetamol and aspirin absorption from Safapryn and Safapryn-Co. Br J Clin Pharmacol (1979) 1.39
Adverse interaction between warfarin and indomethacin. Drug Saf (1994) 1.38
Renal papillary necrosis and aspirin. Scott Med J (1969) 1.38
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Long-term treatment of ventricular arrhythmias with oral mexiletine. Am Heart J (1976) 1.36
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet (2011) 1.32
Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. Proc Natl Acad Sci U S A (1987) 1.31
The gas-liquid chromatographic estimation of phenacetin and paracetamol in plasma and urine. J Pharm Pharmacol (1971) 1.29
Rates of replacement of lecithins and alveolar instability in rat lungs. Am J Physiol (1967) 1.29
Direct determination of volume- and time-dependence of alveolar surface tension in excised lungs. Proc Natl Acad Sci U S A (1978) 1.29
Proceedings: The release of adrenaline and noradrenaline by the adrenal glands of cats and dogs in reflexes arising from the carotid chemoreceptors and baroreceptors. J Physiol (1973) 1.29
Enhancement of oxygen toxicity by the herbicide paraquat. Am Rev Respir Dis (1973) 1.28
Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer (2000) 1.28
Surface active materials from dog lung. I. Method of isolation. Am J Physiol (1972) 1.26
Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Q J Med (1986) 1.26
Lung surfactant proteins, SP-B and SP-C, alter the thermodynamic properties of phospholipid membranes: a differential calorimetry study. Biochemistry (1993) 1.25
Death and blindness due to overdose of quinine. Br Med J (Clin Res Ed) (1985) 1.25
Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scott Med J (1973) 1.25
Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Lancet (1975) 1.25
Why do patients still die from paracetamol poisoning? Br Med J (Clin Res Ed) (1986) 1.25
Alveolar subphase pH in the lungs of anesthetized rabbits. Proc Natl Acad Sci U S A (1981) 1.25
Isolation and properties of type II alveolar cells from rat lung. Am Rev Respir Dis (1977) 1.24
Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord (2001) 1.24
The treatment of acetaminophen poisoning. Annu Rev Pharmacol Toxicol (1983) 1.24
The reflex release of adrenaline and noradrenaline from the adrenal glands of cats and dogs. J Physiol (1980) 1.24
Fatal pulmonary aspiration of oral activated charcoal. BMJ (1988) 1.24